The COVID-19 pandemic is a global health crisis affecting populations around the world. GHTC is tracking and responding to the pandemic through US and multilateral efforts.

As the year comes to a close, we are taking a look back at the top global health innovation stories and news that shaped 2019.

A crisp chill hung in the air one early morning last week as members of the GHTC team stepped up the stairs adjoining the newly refurbished Apple Carnegie Library in Washington, DC, to pose for a photo with more than one hundred fellow research and development (R&D) advocates from across the country.

GHTC held a Game changers in global health game night on Capitol Hill to educate Congressional staffers about the impact of US leadership in global health research and development (R&D). Our guests ate, drank, played games, and learned how US investments in global health R&D not only saves lives around the world, but also generates benefits here at home in the United States. Here are some of our favorite photos.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Two thousand eighteen was a turbulent year in global health. Between reemerging crises, breakthrough scientific discoveries, and the continued looming threat of health research funding cuts, 2018 took us on a roller coaster ride of peril and promise. Now as the year comes to an end, GHTC is taking a moment to reflect on the global health innovation stories and news that shaped 2018.

President Trump signed into law a spending bill that pairs full-year fiscal year (FY) 2019 funding for Labor, Health and Human Services (LHHS) and Defense with a stopgap measure to keep other agencies funded through December—staving off a partial government shutdown on the eve of the end of the fiscal year. Here’s a breakdown of how global health and medical research funding fared.

What global health R&D advocates need to know about the 2018 omnibus spending bill.

2018 is shaping up to be another important year for US policy related to global health and medical research. As Congress returns for a busy work session and the White House continues to roll out policy reforms, here are the top five issues GHTC will be following in 2018.

The threat is real: defunding the US Centers for Disease Control and Prevention  (CDC) puts us all in danger, in every country of the globe.

On Tuesday, the Trump Administration released its full fiscal year 2018 budget proposal. This budget proposes significant cuts to programs that support global health and medical research at the National Institutes of Health, Centers for Disease Control and Prevention, and the US Agency for International Development.

What global health advocates need to know about the President's "skinny" budget.

In this regular feature on Breakthroughs, we highlight the most promising Zika virus vaccine, drug, and diagnostic candidates as well as vector control approaches. 

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

As 2015 draws to a close, the Global Health Technologies Coalition is reflecting on the past year in global health innovation.

After four successful Phase 3 clinical trials enrolling more than 3,500 patients in 18 countries, the European Medicines Agency (EMA) has granted Pyramax® Granules, a pediatric malaria medicine, a positive opinion under Article 58—a mechanism through which the EMA reviews and issues a scientific opinion on products that are not intended for use in Europe.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Last week, we reported on exciting policy language included in the Senate Department of Defense appropriations legislation, and earlier this summer, the House and Senate State and Foreign Operations bills also included recognition of the role that new technologies could play in advancing global health.

As the DC summer kicks into full swing, Congress has had a busy month moving forward fiscal year (FY) 2015 funding legislation for a variety of government programs including global health research and development (R&D).